Impact of China’s National Volume-Based Drug Procurement: A Multilevel Interrupted Time Series Analysis on Medical Expenditures in Hypertensive Patients
NVBP effectively reduced outpatient expenditures among hypertensive patients for the treatment of hypertension, dyslipidaemia, and diabetes, suggesting its potential to alleviate patients' economic burdens. However, the increases in non-drug expenditures and substantial variations in policy effects across hospitals highlight a room for further improvement in policy implementation and overall effectiveness.
Authors
- Yuanjin Zhang (ORCID: https://orcid.org/0000-0002-6455-0963)
- Xin Sun
- Yunxiang Huang (ORCID: https://orcid.org/0000-0001-6231-5639)
- Yulong Jia
- Minghong Yao (ORCID: https://orcid.org/0000-0001-8151-6014)
- Yuning Wang (ORCID: https://orcid.org/0000-0001-7386-1897)
- Kang Zou (ORCID: https://orcid.org/0000-0002-4959-1951)
- Fan Mei (ORCID: https://orcid.org/0000-0003-4285-2749)
- Yan Ren (ORCID: https://orcid.org/0000-0002-1704-7580)
- Qianrui Li (ORCID: https://orcid.org/0000-0003-0780-8531)
- Jing Tan
- Huangang Hu
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Research Center of New Materials (CN)
Publication Details
- Journal
- International Journal of Health Policy and Management
- Published
- 2025-04-07
- DOI
- https://doi.org/10.34172/ijhpm.8540
- Citations
- 1
- Primary Topic
- Global Health Care Issues
- Type
- article
- Field-Weighted Citation Impact
- 2.82